Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine for Postoperative Pain in PCNL
NCT02198027Phase 4Unknown
- Sponsor
- Indus Hospital and Health Network
- Start
- Jul 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain, sponsored by Indus Hospital and Health Network. Primary endpoint: Mean time for first demand of rescue analgesic at 24 hours. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02198027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02198027.